Management of Patients with Antiphospholipid Antibodies Undergoing In Vitro Fertilization

Infertility affects 10–15% of all married couples of reproductive age in the United States and results in substantial emotional distress and medical investment. Though it is uncertain whether antiphospholipid syndrome (APS) is a cause of infertility, inevitably there is a small proportion of women w...

Full description

Saved in:
Bibliographic Details
Published inJournal of autoimmunity Vol. 15; no. 2; pp. 209 - 211
Main Authors Udoff, Laurence C, Branch, D.Ware
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.09.2000
Subjects
Antibodies, Antiphospholipid - blood
antiphospholipid syndrome
Antiphospholipid Syndrome - physiopathology
Female
Fertilization in Vitro - drug effects
Fertilization in Vitro - methods
Humans
Ovulation Induction - methods
ovulation induction in vitro fertilization and embryo transfer, antiphospholipid syndrome, estradiol
ovulation induction in vitro fertilization and embryo transfer, antiphospholipid syndrome, estradiol
Online AccessGet full text

Cover

More Information
Summary:Infertility affects 10–15% of all married couples of reproductive age in the United States and results in substantial emotional distress and medical investment. Though it is uncertain whether antiphospholipid syndrome (APS) is a cause of infertility, inevitably there is a small proportion of women who have both APS and infertility. In turn, some of these patients are candidates for ovulation induction, with or without assisted reproductive technologies, such as
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Feature-3
ObjectType-Review-1
ISSN:0896-8411
1095-9157
DOI:10.1006/jaut.2000.0416